Keyword: Crohn’s disease

Plant Construction & Process Technology

Bioelectronic Medicines: A New Type of Personalization

27.04.2017 - Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...

News

AstraZeneca and Sanofi Swap Compounds

30.11.2015 - Drugs firms AstraZeneca and Sanofi are to exchange 210,000 compounds from their libraries to help boost their search for new small-molecule medicines. The companies have selected...

News

Celgene Offers $7.2 Billion for Receptos

17.07.2015 - US biotech firm Celgene has agreed to pay $7.2 billion, or $232 per share, to acquire compatriot Receptos, a biotech company that makes a potential blockbuster drug to treat...

News

AstraZeneca Sells Gastro Treatment to Swiss Group Tillotts

13.07.2015 - In another move to sharpen its focus on oncology, diabetes and respiratory disorders, AstraZeneca has announced it is selling all non-US rights for Entocort, a treatment for Crohn...